Physician profile
Brandie J Metz
NPI 1639105463
$41,263.45
in general payments reported to CMS, 2019-2025
30 companies · $14K in 2025
The $14K reported for 2025 was more than what 88% of Pediatric Dermatology providers received nationally (typical 2025 total: $302).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $924 · 2020: $12K · 2021: $553 · 2022: $1,920 · 2023: $1,000 · 2024: $11K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $10K · Food and Beverage: $4,849 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,725 · Travel and Lodging: $3,369 · Consulting Fee: $2,400 · Education: $87.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $10,200.00 |
| Food and Beverage | $4,848.72 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,725.00 |
| Travel and Lodging | $3,368.76 |
| Consulting Fee | $2,400.00 |
| Education | $87.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $11,960.75 | 2025 | Vtama |
| Pfizer INC. | $10,145.56 | 2019-2025 | |
| Regeneron Pharmaceuticals, INC. | $9,456.85 | 2019-2020 | |
| Genzyme Corporation | $4,577.63 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $949.51 | 2019-2025 | Dupixent |
| Abbvie INC. | $780.08 | 2021-2025 | |
| Galderma Laboratories, L.P. | $488.02 | 2019-2025 | Aklief, Epsolay, Twyneo |
| Lilly USA, LLC | $449.28 | 2020-2025 | Taltz, Ebglyss |
| Arcutis Biotherapeutics, INC. | $408.66 | 2023-2025 | Zoryve |
| Incyte Corporation | $350.66 | 2021-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $212.97 | 2019-2025 | |
| Leo Pharma INC. | $187.14 | 2023-2025 | Adbry, Anzupgo |
| Sanofi-Aventis U.S. LLC | $156.71 | 2021-2024 | |
| Epi Health, LLC | $155.47 | 2019-2022 | |
| Pierre Fabre Pharmaceuticals, INC. | $150.31 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $146.78 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $118.02 | 2019-2025 | Jublia, Cabtreo, Siliq |
| Strata Skin Sciences, INC. | $116.94 | 2019-2025 | Xtrac |
| Krystal Biotech INC | $93.60 | 2023-2024 | Vyjuvek |
| Journey Medical Corporation | $77.13 | 2019-2024 | |
| Lnhc, INC | $55.64 | 2025 | Zelsuvmi |
| Vyne Pharmaceuticals INC. | $44.56 | 2020-2021 | |
| Prugen, INC. Pharmaceuticals | $37.83 | 2019-2020 | |
| Dermavant Sciences, INC. | $32.60 | 2023-2024 | Vtama |
| Mylan Pharmaceuticals INC. | $23.71 | 2019 | |
| Amgen INC. | $23.15 | 2025 | Otezla |
| Alexion Pharmaceuticals, INC. | $21.02 | 2025 | Koselugo |
| Taro Pharmaceuticals USA, INC. | $19.73 | 2019 | |
| Botanix Sb INC | $14.62 | 2025 | Sofdra |
| Mayne Pharma Commercial LLC | $8.52 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandie Metz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.